Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Shenzhen Jingtai Technology presents Ret inhibitors

July 6, 2021

Roche patents new BRAF inhibitors

July 6, 2021

Antitumor activity of luxeptinib described in phase Ia/b study in B-cell malignancies

July 6, 2021

Venadaparib shows safety and preliminary efficacy in first-in-human trial

July 6, 2021

Initiation of phase II study of HA-121-28 in advanced biliary tract cancer

July 5, 2021

Phase Ib data presented for ulixertinib plus palbociclib in advanced solid tumors

July 5, 2021

Chinese researchers identify new CDK9 inhibitors

July 5, 2021

Omeros divulges new MASP2 inhibitors

July 5, 2021

ALICE study data support iadademstat with azacitidine in acute myeloid leukemia

July 5, 2021

Phase Ib data for triple combination of SHR-6390 plus pyrotinib and letrozole in mBC

July 2, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...